- Home
- CLDX vs NMM Comparison
CLDX vs NMM Comparison
Compare CLDX & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | NMM |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 1995 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CLDX | NMM |
|---|---|---|
| Price | $43.01 | $78.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $46.60 | ★ $85.00 |
| AVG Volume (30 Days) | ★ 929.5K | 90.9K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | $5.57 |
| Revenue Next Year | $235.85 | $3.66 |
| P/E Ratio | ★ N/A | $7.24 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $20.19 | $42.77 |
| 52 Week High | $42.92 | $82.84 |
Technical Indicators
Market Signals| Indicator | CLDX | NMM |
|---|---|---|
| Relative Strength Index (RSI) | 74.14 | 56.67 |
| Support Level | $28.51 | $69.21 |
| Resistance Level | N/A | $81.77 |
| Average True Range (ATR) | 1.61 | 2.43 |
| MACD | 0.54 | -0.01 |
| Stochastic Oscillator | 98.32 | 57.41 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About NMM Navios Maritime Partners LP
Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.